Product Images Beqvez
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Beqvez NDC 0069-2006 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Pfizer Labs, a division of Pfizer Inc. in New York, NY 10001, is the distributor of the mentioned product.*
This text provides information about a medication with the NDC code 0069-0422-01, which is intended for prescription use only. It emphasizes not shaking the product and not refreezing it. The medication, elaparvovec-dzkt, should be stored in a freezer between -90 °C to -60 °C (-130 °F to 76 °F). The recommended dosage is 13 vg/mL, and it is advised for intravenous use only. The medication is a single-dose and contains no preservatives. Additionally, it mentions the manufacturer as Pfizer Inc. stationed in NY, NY. This medication is authorized by US License No. 2001.*
This text provides product information for a pharmaceutical item known as aluap| jusned Jazid. The product is described as elaparvovec-dzkt, with the code noco069-2004-14. Each carton contains 4 single-dose vials, with 11 x 10 vector genomes (vg)/mL for intravenous use only. It requires a prescription for use.*
This text appears to be a product description related to a pharmaceutical item. It mentions a line of products named "Sormemer" and "Siiictisd." The product contains cartons with single-dose vials that have 1 x 10 vector genomes (vg) per milliliter. This indicates that it is an injectable solution intended for intravenous use only with a prescription requirement.*
This text provides information about a pharmaceutical product called fidanacogene elaparvovec-dzkt. It states that each carton contains 6 single-dose vials with 1 x 10^13 vector genomes (vg)/mL. The product is an injection for intravenous use only and is labeled as Rx only.*
The text provides information about a pharmaceutical product named fidanacogene elaparvovec-dzkt, marketed under the brand BEQVEZ™. It mentions the concentration of 1 x 10" vector genomes (vg)/mL and specifies that it is an injection for intravenous use only. The product is packaged in cartons containing 7 single-dose vials. This text is a label and includes information like lot numbers, expiration dates, and National Drug Code (NDC) numbers.*
This is a detailed product description for a medication named BEQVEZ™ by Pfizer. It is a single-dose vial for intravenous use only, containing fidanacogene elaparvovec-dzkt. The medication must be stored frozen at temperatures between -100 °C to -60 °C (-148 °F to -76 °F). The vial contains 103 vector genomes (vg)/mL and is from a batch manufactured by Pfizer Inc. Upon receipt, the vial should be placed in a freezer between -90 °C to -60 °C (-130 °F to -76 °F). This information also includes the product's expiration date, lot number, and quantity.*
This is a description of a medication with the brand name BEQVEZ™ manufactured by Pfizer Inc. Each carton contains 5 single-dose vials. The medication is for intravenous use only and should be stored in a freezer between -90°C to -60°C (-130°F to -76°F). The package includes a patient identifier and unique identifiers for tracking and distribution. The medication contains fidanacogene elaparvovec-dzkt and has a concentration of 1 x 10^3 vector genomes (vg)/mL.*
This is a description of a pharmaceutical product with the NDC code 0069-2006-06 manufactured by Pfizer. It contains a carton with 6 single-dose vials of fidanacogene elaparvovec-dzkt under the brand name BEQVEZ™ for intravenous use only. The product is stored and delivered frozen at temperatures between -100°C to -60°C and should be placed in a freezer between -90°C to -60°C upon receipt. The expiration date, lot number, and quantity are specified on the packaging.*
This is a description of a Pfizer medication called BEQVEZ™ with the active ingredient fidanacogene elaparvovec-dzkt. Each package contains 7 single-dose vials. The medication is for intravenous use only and contains 1 x 10^3 vector genomes (vg)/mL. BEQVEZ™ is stored and delivered frozen at temperatures between -100 °C to -60 °C (-148 °F to -76 °F) and upon receipt should be placed in a freezer between -90 °C to -60 °C (-130 °F to -76 °F). The medication has an expiration date and a specific lot number for tracking purposes. The medication is manufactured by Pfizer Inc. in New York, NY.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.